Citigroup’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-583
Closed -$5K 6464
2022
Q2
$5K Buy
583
+124
+27% +$1.26K ﹤0.01% 5642
2022
Q1
$7K Sell
459
-829
-64% -$14.4K ﹤0.01% 5710
2021
Q4
$34K Buy
1,288
+674
+110% +$25.6K ﹤0.01% 5236
2021
Q3
$30K Buy
614
+227
+59% +$14K ﹤0.01% 5038
2021
Q2
$33K Buy
387
+11
+3% +$945 ﹤0.01% 5035
2021
Q1
$38K Sell
376
-623
-62% -$68.5K ﹤0.01% 4868
2020
Q4
$101K Buy
999
+745
+293% +$49.7K ﹤0.01% 5534
2020
Q3
$12K Sell
254
-179
-41% -$9.19K ﹤0.01% 6525
2020
Q2
$25K Buy
+433
New +$28.9K ﹤0.01% 6458

Other funds holding AWH

Citigroup's AWH Position: Q3 2022 in Review

Citigroup sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2022, closing a stake of 583 shares — an estimated $5K sold.

Citigroup first reported a position in AWH in Q2 2020 and held it in 9 quarters. The position peaked at $101K in Q4 2020. 58 funds tracked by Wall St. Rank hold AWH as of Q3 2022.

  • Citigroup reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 583 Aspira Women's Health Inc. Common Stock shares in Q3 2022, an estimated $5K.
  • Citigroup first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Citigroup's Aspira Women's Health Inc. Common Stock position peaked at $101K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.